Skip to main content
. Author manuscript; available in PMC: 2015 Jan 22.
Published in final edited form as: Liver Int. 2008 Apr 7;28(7):1026–1033. doi: 10.1111/j.1478-3231.2008.01723.x

Table 2.

The mean ±SD (and median) of percent excretion of different sugar probes in baseline urine permeability test and aspirin challenge permeability test in healthy controls, steatosis and non-alcoholic steatohepatitis in 5 and 24 h urine collection

Healthy control (n = 12)
Steatosis (n = 6)
NASH (n = 10)
Baseline Aspirin challenge Baseline Aspirin challenge Baseline Aspirin challenge
Lactulose (5-h urine) 0.07 ± 0.05 (0.05) 0.06 ± 0.028 (0.07) 0.23 ± 0.15 (0.18) 0.17 ± 0.08 (0.19) 0.14 ± 0.12 (0.10) 0.62 ± 0.82 (0.39)
Mannitol (5-h urine) 10.7 ± 9.1 (9.8) 6.8 ± 2.9 (6.6) 15.0 ± 4.9 (14.0) 12.7 ± 8.0 (12.1) 18.5 ± 12.1 (19.0) 20.0 ± 12.9 (14.8)
L/M ratio (5-h urine) 0.007 ± 0.003 (0.006) 0.01 ± 0.005* (0.009) 0.015 ± 0.008 (0.013) 0.015 ± 0.001 (0.015) 0.020 ± 0.035 (0.008) 0.033 ± 0.034* (0.03)
Sucralose (24-h urine) 2.49 ± 1.34 (2.08) 2.62 ± 1.68 (2.49) 3.07 ± 0.87 (3.23) 4.11 ± 1.60 (4.05) 2.79 ± 1.55 (2.90) 7.70 ± 4.48 *#θ (6.3)
*

P < 0.05 vs. healthy control at baseline.

#

P < 0.05 vs. NASH at baseline.

θ

P < 0.05 vs. steatosis post-aspirin.

L/M, lactulose/mannitol; NASH, non-alcoholic steatohepatitis; SD, standard deviation.